Italia markets closed

TEVA Jul 2024 16.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,3500-0,3000 (-46,15%)
In data: 03:37PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,6500
Aperto0,4900
Denaro0,3400
Domanda0,4400
Prezzo d'esercizio16,00
Scadenza2024-07-05
Min-Max giorno0,3300 - 0,4900
Contratto - Min-MaxN/D
Volume29
Open Interest93
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.